LEGN logo

Legend Biotech (LEGN) Cash from financing

annual CFF:

$5.70M-$785.79M(-99.28%)
December 31, 2024

Summary

  • As of today (June 29, 2025), LEGN annual cash flow from financing activities is $5.70 million, with the most recent change of -$785.79 million (-99.28%) on December 31, 2024.
  • During the last 3 years, LEGN annual CFF has fallen by -$620.97 million (-99.09%).
  • LEGN annual CFF is now -99.28% below its all-time high of $791.49 million, reached on December 31, 2023.

Performance

LEGN Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNcash flow metrics

quarterly CFF:

$667.00K+$1.00M(+300.30%)
March 31, 2025

Summary

  • As of today (June 29, 2025), LEGN quarterly cash flow from financing activities is $667.00 thousand, with the most recent change of +$1.00 million (+300.30%) on March 31, 2025.
  • Over the past year, LEGN quarterly CFF has dropped by -$164.00 thousand (-19.74%).
  • LEGN quarterly CFF is now -99.92% below its all-time high of $790.05 million, reached on June 30, 2023.

Performance

LEGN quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNcash flow metrics

TTM CFF:

$5.53M-$164.00K(-2.88%)
March 31, 2025

Summary

  • As of today (June 29, 2025), LEGN TTM cash flow from financing activities is $5.53 million, with the most recent change of -$164.00 thousand (-2.88%) on March 31, 2025.
  • Over the past year, LEGN TTM CFF has dropped by -$787.23 million (-99.30%).
  • LEGN TTM CFF is now -99.53% below its all-time high of $1.17 billion, reached on June 30, 2023.

Performance

LEGN TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

LEGN Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-99.3%-19.7%-99.3%
3 y3 years-99.1%+2568.0%-99.1%
5 y5 years-61.1%-99.5%-95.9%

LEGN Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-99.3%at low-99.9%+185.2%-99.5%+50.7%
5 y5-year-99.3%at low-99.9%+185.2%-99.5%+50.7%
alltimeall time-99.3%+127.8%-99.9%+109.3%-99.5%+50.7%

LEGN Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
$667.00K(-300.3%)
$5.53M(-2.9%)
Dec 2024
$5.70M(-99.3%)
-$333.00K(-107.8%)
$5.70M(-18.1%)
Sep 2024
-
$4.25M(+344.5%)
$6.96M(+89.4%)
Jun 2024
-
$955.00K(+14.9%)
$3.67M(-99.5%)
Mar 2024
-
$831.00K(-10.2%)
$792.76M(+0.2%)
Dec 2023
$791.49M(+109.4%)
$925.00K(-3.7%)
$791.49M(+0.2%)
Sep 2023
-
$961.00K(-99.9%)
$789.78M(-32.3%)
Jun 2023
-
$790.05M(<-9900.0%)
$1.17B(+209.0%)
Mar 2023
-
-$444.00K(-43.3%)
$377.51M(-0.1%)
Dec 2022
$377.98M(-39.7%)
-$783.00K(-100.2%)
$377.98M(-46.2%)
Sep 2022
-
$377.73M(>+9900.0%)
$702.32M(+115.6%)
Jun 2022
-
$1.01M(+3936.0%)
$325.74M(-48.0%)
Mar 2022
-
$25.00K(-100.0%)
$626.48M(-0.0%)
DateAnnualQuarterlyTTM
Dec 2021
$626.66M(+1.3%)
$323.56M(>+9900.0%)
$626.66M(+106.3%)
Sep 2021
-
$1.14M(-99.6%)
$303.76M(-2.7%)
Jun 2021
-
$301.75M(>+9900.0%)
$312.28M(-33.6%)
Mar 2021
-
$207.00K(-68.7%)
$470.33M(-24.0%)
Dec 2020
$618.88M(+4119.8%)
$661.00K(-93.2%)
$618.88M(+1.2%)
Sep 2020
-
$9.66M(-97.9%)
$611.54M(+1.6%)
Jun 2020
-
$459.80M(+209.1%)
$601.72M(+346.6%)
Mar 2020
-
$148.75M(-2326.9%)
$134.74M(+818.8%)
Dec 2019
$14.67M(+486.4%)
-$6.68M(+4237.7%)
$14.67M(-31.3%)
Sep 2019
-
-$154.00K(-97.9%)
$21.35M(-0.7%)
Jun 2019
-
-$7.18M(-125.0%)
$21.50M(-25.0%)
Mar 2019
-
$28.68M
$28.68M
Dec 2018
$2.50M
-
-

FAQ

  • What is Legend Biotech annual cash flow from financing activities?
  • What is the all time high annual CFF for Legend Biotech?
  • What is Legend Biotech annual CFF year-on-year change?
  • What is Legend Biotech quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Legend Biotech?
  • What is Legend Biotech quarterly CFF year-on-year change?
  • What is Legend Biotech TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Legend Biotech?
  • What is Legend Biotech TTM CFF year-on-year change?

What is Legend Biotech annual cash flow from financing activities?

The current annual CFF of LEGN is $5.70M

What is the all time high annual CFF for Legend Biotech?

Legend Biotech all-time high annual cash flow from financing activities is $791.49M

What is Legend Biotech annual CFF year-on-year change?

Over the past year, LEGN annual cash flow from financing activities has changed by -$785.79M (-99.28%)

What is Legend Biotech quarterly cash flow from financing activities?

The current quarterly CFF of LEGN is $667.00K

What is the all time high quarterly CFF for Legend Biotech?

Legend Biotech all-time high quarterly cash flow from financing activities is $790.05M

What is Legend Biotech quarterly CFF year-on-year change?

Over the past year, LEGN quarterly cash flow from financing activities has changed by -$164.00K (-19.74%)

What is Legend Biotech TTM cash flow from financing activities?

The current TTM CFF of LEGN is $5.53M

What is the all time high TTM CFF for Legend Biotech?

Legend Biotech all-time high TTM cash flow from financing activities is $1.17B

What is Legend Biotech TTM CFF year-on-year change?

Over the past year, LEGN TTM cash flow from financing activities has changed by -$787.23M (-99.30%)
On this page